Total Payments
$1.9M
2024 Payments
$62,320
Companies
23
Transactions
436
Medicare Patients
4,140
Medicare Billing
$451,220
Payment Breakdown by Category
Consulting$1.3M (68.3%)
Other$510,700 (27.6%)
Royalty/License$51,072 (2.8%)
Food & Beverage$13,698 (0.7%)
Travel$12,028 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1.3M | 205 | 68.3% |
| Grant | $224,661 | 17 | 12.1% |
| Acquisitions | $169,539 | 1 | 9.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $85,937 | 11 | 4.6% |
| Royalty or License | $51,072 | 1 | 2.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $30,562 | 2 | 1.6% |
| Food and Beverage | $13,698 | 163 | 0.7% |
| Travel and Lodging | $12,028 | 36 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GLAUKOS CORPORATION | $508,381 | 72 | $0 (2022) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $372,829 | 57 | $0 (2023) |
| Apellis Pharmaceuticals, Inc. | $272,143 | 30 | $0 (2024) |
| Alcon Vision LLC | $172,633 | 31 | $0 (2024) |
| Alcon Research LLC | $171,528 | 46 | $0 (2022) |
| Sight Sciences, Inc. | $113,678 | 65 | $0 (2024) |
| Allergan, Inc. | $69,429 | 44 | $0 (2021) |
| Ivantis, Inc | $67,320 | 17 | $0 (2021) |
| Ocular Therapeutix, Inc. | $58,914 | 22 | $0 (2021) |
| Alcon Laboratories Inc | $25,783 | 21 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $62,320 | 22 | Apellis Pharmaceuticals, Inc. ($40,600) |
| 2023 | $237,803 | 43 | Apellis Pharmaceuticals, Inc. ($152,250) |
| 2022 | $375,190 | 64 | Alcon Vision LLC ($171,032) |
| 2021 | $211,183 | 36 | Glaukos Corporation ($92,597) |
| 2020 | $218,024 | 45 | Novartis Pharmaceuticals Corporation ($65,804) |
| 2019 | $251,677 | 85 | Glaukos Corporation ($101,179) |
| 2018 | $231,318 | 55 | Glaukos Corporation ($130,021) |
| 2017 | $265,714 | 86 | Glaukos Corporation ($96,940) |
All Payment Transactions
436 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $7,875.00 | General |
| Category: Ophthalmology | ||||||
| 10/20/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $47.94 | General |
| Category: Ophthalmology | ||||||
| 08/22/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $130.71 | General |
| Category: Ophthalmology | ||||||
| 08/14/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $68.07 | General |
| Category: Ophthalmology | ||||||
| 07/31/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,875.00 | General |
| Category: Ophthalmology | ||||||
| 07/24/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $43.14 | General |
| Category: Ophthalmology | ||||||
| 07/17/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,750.00 | General |
| Category: Ophthalmology | ||||||
| 07/12/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Consulting Fee | Cash or cash equivalent | $3,850.00 | General |
| Category: Ophthalmology | ||||||
| 07/12/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $145.13 | General |
| Category: Ophthalmology | ||||||
| 06/14/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Consulting Fee | Cash or cash equivalent | $4,200.00 | General |
| Category: Ophthalmology | ||||||
| 06/10/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $134.85 | General |
| Category: Ophthalmology | ||||||
| 06/01/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $121.56 | General |
| Category: EYE CARE | ||||||
| 05/03/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Consulting Fee | Cash or cash equivalent | $4,550.00 | General |
| Category: Ophthalmology | ||||||
| 04/17/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $68.22 | General |
| Category: Ophthalmology | ||||||
| 04/07/2024 | Alcon Vision LLC | AcrySof (Device) | Food and Beverage | In-kind items and services | $113.54 | General |
| Category: Ophthalmology | ||||||
| 03/15/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Consulting Fee | Cash or cash equivalent | $4,725.00 | General |
| Category: Ophthalmology | ||||||
| 03/13/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $40.58 | General |
| Category: Ophthalmology | ||||||
| 03/12/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $128.35 | General |
| Category: Ophthalmology | ||||||
| 01/25/2024 | Johnson & Johnson Surgical Vision, Inc. | Tecnis Simplicity (Device), Tecnis IOL, Tecnis IOL | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Optics | ||||||
| 01/19/2024 | Apellis Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $13,650.00 | General |
| 01/19/2024 | Apellis Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $9,625.00 | General |
| 01/19/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $153.92 | General |
| Category: Ophthalmology | ||||||
| 12/28/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $12,750.00 | General |
| 12/20/2023 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $4,375.00 | General |
| Category: Ophthalmology | ||||||
| 12/13/2023 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $64.20 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 949 | 1,737 | $518,240 | $137,736 |
| 2022 | 9 | 1,036 | 1,814 | $399,241 | $118,283 |
| 2021 | 10 | 1,131 | 1,833 | $438,404 | $124,782 |
| 2020 | 8 | 1,024 | 1,578 | $321,765 | $70,420 |
Total Patients
4,140
Total Services
6,962
Medicare Billing
$451,220
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 403 | 1,026 | $122,646 | $82,206 | 67.0% |
| 66170 | Creation of eye fluid drainage tract for treatment of glaucoma | Facility | 2023 | 16 | 17 | $131,750 | $18,448 | 14.0% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 24 | 33 | $170,478 | $15,233 | 8.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 100 | 166 | $14,204 | $9,104 | 64.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 306 | 376 | $68,242 | $9,028 | 13.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $2,730 | $1,315 | 48.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 39 | $1,638 | $1,164 | 71.1% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 28 | 28 | $3,780 | $773.69 | 20.5% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 20 | 20 | $1,920 | $352.62 | 18.4% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 17 | 17 | $852.00 | $110.40 | 13.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 410 | 955 | $112,988 | $73,744 | 65.3% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 28 | 37 | $191,142 | $17,736 | 9.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 172 | 298 | $23,692 | $14,392 | 60.7% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 334 | 411 | $61,239 | $8,676 | 14.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $3,094 | $1,686 | 54.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 37 | $1,808 | $946.15 | 52.3% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 26 | 26 | $2,800 | $670.12 | 23.9% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 18 | 18 | $1,728 | $329.06 | 19.0% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 15 | 15 | $750.00 | $103.85 | 13.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 400 | 805 | $91,960 | $61,125 | 66.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 244 | 434 | $35,282 | $23,460 | 66.5% |
| 66170 | Treatment for glaucoma with creation of eye fluid drainage, primary | Facility | 2021 | 13 | 13 | $100,750 | $13,565 | 13.5% |
| 66984 | Removal of cataract with insertion of lens, simple | Facility | 2021 | 20 | 26 | $134,316 | $12,395 | 9.2% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 352 | 452 | $64,184 | $9,952 | 15.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $4,968 | $2,777 | 55.9% |
About Dr. Kuldev Singh, MD
Dr. Kuldev Singh, MD is a Ophthalmology healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1093852253.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kuldev Singh, MD has received a total of $1.9M in payments from pharmaceutical and medical device companies, with $62,320 received in 2024. These payments were reported across 436 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($1.3M).
As a Medicare-enrolled provider, Singh has provided services to 4,140 Medicare beneficiaries, totaling 6,962 services with total Medicare billing of $451,220. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Stanford, CA
- Active Since 01/30/2007
- Last Updated 03/21/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1093852253
Products in Payments
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $226,120
- HYDRUS Microstent (Device) $184,997
- iStent Trabecular Micro-Bypass Stent System (Device) $157,656
- CyPass (Device) $121,447
- BROLUCIZUMAB (Drug) $47,455
- OMNI SURGICAL SYSTEM (Device) $41,964
- OMNI(R) SURGICAL SYSTEM (US) (Device) $40,921
- Hydrus (Device) $40,145
- ReSure Sealant (Device) $39,153
- OMNI (Device) $29,687
- AcrySof (Device) $28,614
- Hydrus Microstent (Device) $27,175
- DEXTENZA (Drug) $19,761
- Syfovre (Drug) $17,325
- XEN (Device) $6,538
- Rhopressa (Drug) $6,476
- Durezol (Drug) $6,270
- Simbrinza (Drug) $4,703
- Ophthalmic Surgical Adjuncts (Device) $3,438
- DUREZOL (Drug) $2,129
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Stanford
Ehsan Rahimy, Md, MD
Ophthalmology — Payments: $1.3M
Ophthalmology $1.3M
Quan Nguyen, Md, MD
Ophthalmology — Payments: $999,300
Ophthalmology $999,300
Diana Do, Md, MD
Ophthalmology — Payments: $383,793
Ophthalmology $383,793
Theodore Leng, Md, MD
Ophthalmology — Payments: $246,136
Ophthalmology $246,136
Robert Chang, Md, MD
Ophthalmology — Payments: $107,945
Ophthalmology $107,945
Ramsudha Narala, Md, MD
Ophthalmology — Payments: $96,310
Ophthalmology $96,310